Literature DB >> 17122076

Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice.

Pascal Clerc1, Maria Gràcia Coll Constans, Hubert Lulka, Stéphanie Broussaud, Charlotte Guigné, Stéphane Leung-Theung-Long, Christophe Perrin, Claude Knauf, Christian Carpéné, Luc Pénicaud, Catherine Seva, Rémy Burcelin, Philippe Valet, Daniel Fourmy, Marlène Dufresne.   

Abstract

The role of cholecystokinin (CCK) as a satiety factor has been extensively documented. Although most work implies that CCK1 receptor mediates the control of food intake, a contributing role for CCK2 receptor (CCK2R) in the CCK-induced satiety cannot be totally excluded. The hypothesis that CCK2R invalidation disrupts regulatory pathways with impact on feeding behavior was examined in CCK2R(-/-) mice. CCK2R(-/-) mice developed obesity that was associated with hyperphagia. Obesity was related with increased fat deposition resulting from adipocyte hypertrophy. Expression of several adipokines was dysregulated consistently with obesity. Moreover, obesity was associated with disturbed glucose homeostasis as revealed by increased fasting glycemia and insulinemia, impaired glucose tolerance, and hepatic insulin resistance in CCK2R(-/-) mice. In vitro analysis of isolated adipocytes metabolism was consistent with increased storage but preserved insulin sensitivity. Suppression of feeding and concomitant increased expression of hypothalamic proopiomelanocortin after intracerebroventricular injection of gastrin into control mice demonstrates that hypothalamic CCK2 receptors mediate inhibition of food intake. Comparative analysis of hypothalamic mediator gene expression in fed knockout and control mice demonstrated overexpression of ghrelin receptors in CCK2R(-/-) mice, indicating up-regulation of orexigenic pathways. This effect was also observed after body weight normalization, indicating a causative role in the development of hyperphagia and obesity of CCK2R(-/-) mice. Our results give evidence that CCK2 receptor activity plays a contributing regulatory role in the control of food intake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122076     DOI: 10.1210/en.2006-1064

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Role of parathyroid hormone-related protein in the pro-inflammatory and pro-fibrogenic response associated with acute pancreatitis.

Authors:  Vandanajay Bhatia; Sung O K Kim; Judith F Aronson; Celia Chao; Mark R Hellmich; Miriam Falzon
Journal:  Regul Pept       Date:  2012-01-23

2.  Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol.

Authors:  Wenda Wu; Hui-Ren Zhou; Kaiyu He; Xiao Pan; Yoshiko Sugita-Konishi; Maiko Watanabe; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2014-01-02       Impact factor: 4.849

Review 3.  Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Protein Pept Sci       Date:  2011-06       Impact factor: 3.272

4.  Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.

Authors:  Helene Johannessen; David Revesz; Yosuke Kodama; Nikki Cassie; Karolina P Skibicka; Perry Barrett; Suzanne Dickson; Jens Holst; Jens Rehfeld; Geoffrey van der Plasse; Roger Adan; Bård Kulseng; Elinor Ben-Menachem; Chun-Mei Zhao; Duan Chen
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

5.  Life-span extension by dietary restriction is mediated by NLP-7 signaling and coelomocyte endocytosis in C. elegans.

Authors:  Sang-Kyu Park; Christopher D Link; Thomas E Johnson
Journal:  FASEB J       Date:  2009-09-25       Impact factor: 5.191

6.  Microarray analysis of differentially expressed genes in the brains of tubby mice.

Authors:  Jeong Ho Lee; Chul Hoon Kim; Dong Goo Kim; Young Soo Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

7.  Effect of proton pump inhibitors on glycemic control in patients with diabetes.

Authors:  Kohzo Takebayashi; Toshihiko Inukai
Journal:  World J Diabetes       Date:  2015-08-25

8.  Tripeptidyl peptidase II promotes fat formation in a conserved fashion.

Authors:  Renée M McKay; James P McKay; Jae Myoung Suh; Leon Avery; Jonathan M Graff
Journal:  EMBO Rep       Date:  2007-10-12       Impact factor: 8.807

9.  Cholecystokinin Switches the Plasticity of GABA Synapses in the Dorsomedial Hypothalamus via Astrocytic ATP Release.

Authors:  Karen M Crosby; Ciaran Murphy-Royal; Sarah A Wilson; Grant R Gordon; Jaideep S Bains; Quentin J Pittman
Journal:  J Neurosci       Date:  2018-08-14       Impact factor: 6.167

10.  Alterations in activity and energy expenditure contribute to lean phenotype in Fischer 344 rats lacking the cholecystokinin-1 receptor gene.

Authors:  James E Blevins; Daniel H Moralejo; Tami H Wolden-Hanson; Brendan S Thatcher; Jacqueline M Ho; Karl J Kaiyala; Kozo Matsumoto
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-31       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.